| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $18.3M | +41.6% |
| Cost of Revenue | $9.2M | +37.4% |
| Gross Profit | $9.1M | +46.1% |
| R&D Expense | $5.0M | +38.6% |
| SG&A Expense | $10.7M | -2.7% |
| Operating Income | -$15.1M | +2.9% |
| Interest Expense | $302K | +93.6% |
| Pre-tax Income | -$15.2M | -0.8% |
| Net Income | -$15.2M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.6M | -57.9% |
| Accounts Receivable | $5.6M | +22.1% |
| Inventory | $5.0M | -2.6% |
| Current Assets | $20.2M | -34.9% |
| Total Assets | $28.9M | -29.3% |
| Current Liabilities | $8.1M | -11.8% |
| Total Liabilities | $16.3M | +5.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.1M | +17.9% |
| Capital Expenditures | $157K | -19.1% |
| Investing Cash Flow | -$157K | +97.0% |
| Financing Cash Flow | $348K | — |
| Free Cash Flow | -$12.2M | +17.9% |
| -0.8% |
| EPS (Basic) | -$1.10 | +5.2% |
| EPS (Diluted) | -$1.10 | +5.2% |
| Stockholders' Equity |
| $12.6M |
| -50.5% |